Inactive Instrument

Victrex plc Stock London S.E.

Equities

VCT

Specialty Chemicals

End-of-day quote London S.E.
- GBX - Intraday chart for Victrex plc

Financials

Sales 2024 * 297M 385M 526M Sales 2025 * 320M 415M 567M Capitalization 967M 1.25B 1.72B
Net income 2024 * 37M 47.99M 65.63M Net income 2025 * 62M 80.41M 110M EV / Sales 2024 * 3.28 x
Net Debt 2024 * 6.34M 8.22M 11.25M Net cash position 2025 * 20.25M 26.27M 35.93M EV / Sales 2025 * 2.96 x
P/E ratio 2024 *
31.8 x
P/E ratio 2025 *
15.4 x
Employees -
Yield 2024 *
5.39%
Yield 2025 *
5.57%
Free-Float 98.37%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 17-08-31
Director of Finance/CFO - -
Director of Finance/CFO - 22-07-03
Members of the board TitleAgeSince
Chief Executive Officer 60 17-08-31
Chairman 64 21-11-30
Director/Board Member 68 18-02-08
More insiders
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
More about the company